1814 J . Org. Chem., Vol. 65, No. 6, 2000
Frimer et al.
16b, and 19. It should be noted that both 16a and 16b were
obtained as a mixture of diastereomers and partially contami-
nated by cycloheptanone and enones 12a or 12b (presumably
formed via retroaldol and dehydration, respectively; see below).
Attempts to purify 16a and 16b by distillation merely in-
creased the amount of contamination. As a result, 1H NMR
data could not be assigned, though 13C NMR and HRMS data
could be readily extracted. Acid (H2SO4)-catalyzed dehydration
of the latter in methanol, following the method of Friedrich
and co-workers,9 yielded the corresponding enones 12a (Z:E
) 1:1), 12b (Z:E ) 1:1) and 20 in 50% yield. The residue was
predominantly the corresponding cycloheptanone or cyclo-
octanone, presumably regenerated via a retroaldol process.
Azeotropic dehydration of 19 in refluxing benzene (using
p-TsOH and a Dean-Stark trap) generated 20 in 75% yield,
E-12b: Rf (10% ethyl acetate in hexane) 0.35; 1H NMR
(CDCl3) δ 2.59-2.44 (m, 2H), 2.38-2.25 (m, 2H), 2.19 (2q, J 3′,4′
) 7 Hz, 2H), 1.77 (s, 3H), 1.76-1.59 (m, 6H), 1.02 (t, J 3′,4′ ) 7
Hz, 3H); 13C NMR (CDCl3) δ 209.50, 142.85, 136.31, 43.91,
30.67, 29.22, 28.38, 27.73, 24.56, 19.47, 12.20; HRMS calcd
(C11H18O, M+) 166.1358, obsd 166.1351.
15: 1H NMR* (CDCl3) δ 4.98 (t, J 2,3 ) 6 Hz, 1H), 2.19 (m,
2H), 1.96 (m, 2H), 1.65 (m, 2H), 1.53 (m, 2H), 1.49 (m, 2H),
0.14 (s, 9H); 13C NMR* (CDCl3) δ 155.93, 108.55, 35.45, 31.51,
27.74, 25.29, 25.17, 0.16; MS (CI, 70 ev) m/z 185 (MH+, 1.83%),
113 (MH+ - HSiMe3, 49.49%), 95 (MH+ - HOSiMe3, 14.58%);
HRMS (CI) calcd (C10H21OSi, MH+) 185.1361, obsd 185.1360.
16a : Mixture of diastereomers: MS (CI, 70 ev) m/z 199
(MH+, 14%), 181 (MH+ - H2O, 100%), 113 (MH+ - C5H10O,
89%); HRMS calcd (C12H23O2, M+) 199.1698, obsd 199.1670.
Major diastereomer: 13C NMR* (CDCl3) δ 219.35, 75.77, 55.81,
44.27, 35.08, 28.25, 27.94, 23.87, 23.57, 19.87, 16.94, 15.81.
Minor diastereomer: 13C NMR* (CDCl3) δ 218.86, 75.04, 55.66,
43.32, 33.07, 27.87, 27.72, 24.36, 23.63, 19.59, 17.57, 16.23.
16b: Mixture of diastereomers: MS (CI, 70 ev) m/z 185
(MH+, 15%), 167 (MH+ - H2O, 100%), 113 (MH+ - C4H8O,
38%); HRMS (CI) calcd (C11H21O2, MH+) 185.1541, obsd
185.1520. Major diastereomer: 13C NMR* (CDCl3) δ 218.79,
73.57, 57.99, 44.09, 32.95, 28.31, 28.20, 25.61, 23.81, 22.96,
7.55. Minor diastereomer: 13C NMR* (CDCl3) δ 218.20, 73.38,
57.42, 44.03, 31.34, 28.26, 28.11, 25.15 (C3), 24.25 (C6), 23.78
(C1′), 7.40 (C4′).
1
again accompanied by cyclooctanone In the H NMR below of
20, H1′ are the hydrogens on the isopropylidenyl methyl which
is cis to the carbonyl, while H3′ are those that are on the trans
methyl.
(c) Cyclop r op en e Ep oxid a tion P r oced u r e. Enone 20
was also synthesized via the MCPBA epoxidation of cyclopro-
pene 26 in CCl4. GC of the product mixture gave the desired
product along with an as yet unidentified isomer. The MCPBA
epoxidation of 14a and 14b is reported in the literature to yield
E- and Z-12a and 12b, respectively.9
8: 1H NMR (CDCl3) δ 5.94 (t, J 2,3 ) 6.5 Hz, 1H), 2.57-2.52
(m, 2H), 2.11 (m, 2H), 1.71-1.57 (m, 8H); 13C NMR (CDCl3) δ
136.16, 128.77, 38.38, 30.72, 27.79, 26.71, 25.93.
9a : 1H NMR (CDCl3) δ 6.17 (dd, J 1,7a ) 6 Hz, J 1,7b ) 7 Hz,
18: 1H NMR* (CDCl3) δ 4.70 (t, J 2,3 ) 8 Hz, 1H), 2.14 (m,
2H), 1.97 (m, 2H), 1.55 (m, 2H), 1.49 (m, 2H), 1.46 (m, 4H),
0.16 (s, 9H); 13C NMR* (CDCl3) δ 153.05, 105.45, 31.05, 30.98,
27.83, 26.40, 26.36, 25.52, 0.45; MS (EI, 70 ev) m/z 198 (M+,
26.19%), 183 (M+ - CH3, 36.00%), 115 (M+ - CHCOSiMe3,
29.16%); HRMS calcd (C11H22OSi, M+) 198.1439, obsd 198.1400.
1H), 3.77 (dd, J 3,4a ) 4 Hz, J 3,4b ) 6, 1H), 2.90 (sept, J 2′,3′
)
J 2′,3′′ ) 7 Hz, 1H), 2.22-1.32 (m, 8H), 1.14 (d, J 2′,3′ ) 7, 3H),
1.10 (d, J 2′,3′′ ) 7 Hz, 3H); 13C NMR (CDCl3) δ 211.99, 132.29,
132.20, 59.34, 38.96, 27.90, 26.78, 26.11, 25.96, 18.83, 18.46.
9b:1H NMR (CDCl3) δ 6.16 (t, J 1,7 ) 6.6 Hz, 1H), 3.54 (dd,
J 3,4a ) 3.5 Hz, J 3,4b ) 6.5 Hz, 1H), 2.62 and 2.60 (ABq of q,
J gem ) 18.5 Hz, J 2′,3′ ) 7 Hz, 2H), 1.85-1.42 (m, 8H), 1.08 (t,
J 2′,3′ ) 7 Hz, 3H); 13C NMR (CDCl3) δ 208.07, 132.44, 132.06,
60.93, 34.28, 27.98, 26.97, 26.08, 25.96, 7.83.
19: 1H NMR* (CDCl3) δ 3.52 (bs, 1H, OH), 2.55 (dd, J 2,3a
)
4 Hz, J 2,3b ) 11 Hz, 1H, H2), 2.12 (m, 2H), 1.62-1.25 (m, 10H),
0.93 (s, 3H), 0.92 (s, 3H); 13C NMR* (CDCl3) δ 222.61, 71.13,
56.38, 45.39, 29.04, 28.36, 27.91, 26.73, 24.69, 24.64, 22.83;
MS (CI, 70 ev) m/z 185 (MH+, 100%), 167 (MH+ - H2O, 56%);
HRMS (CI) calcd (C11H21O2, MH+) 185.1541, obsd 185.1560.
20: 1H NMR (CDCl3) δ 2.53 (inv quint, J ) 3 Hz, 2H), 2.50-
2.45 (m, 2H), 1.84 (s, 3H), 1.79 (s, 3H), 1.83-1.75 (m, 2H),
1.60-1.51 (m, 4H), 1.47-1.42 (m, 2H); 13C NMR (CDCl3) δ
212.48, 136.66, 136.06, 49.51, 29.05, 27.61, 27.22, 26.65, 25.72,
10a : 1H NMR (CDCl3) δ 3.87 (s, 4H), 3.18 (dd, J 6,7a ) 4 Hz,
J 6,7b ) 10 Hz, 1H), 2.80 (sept, J 2′,3′ ) J 2′,3′′ ) 7 Hz, 1H), 2.10-
1.30 (m, 10H),1.04 (d, J 2′,3′ ) J 2′,3′′ ) 7 Hz, 6H); 13C NMR
(CDCl3) δ 214.79, 112.76, 64.51, 63.94, 57.05, 41.96, 37.48,
28.27, 26.63, 26.51, 22.47, 18.36, 17.58.
22.70, 21.23; IR (CDCl3) 1667 (s, CdO), 1600 (m, CdC) cm-1
;
10b: 1H NMR (CDCl3) δ 3.89-3.84 (m, 4H), 2.99 (dd, J 6,7a
) 10 Hz, J 6,7b ) 4 Hz, 1H), 2.62 and 2.40 (ABq of q, J gem ) 18
Hz, J vic ) 7 Hz, 2H), 1.88-1.50 (m, 10H), 1.02 (t, J 2′,3′ ) 7 Hz,
3H); 13C NMR (CDCl3) δ 211.62, 112.65, 64.58, 63.86, 59.20,
37.43, 36.87, 26.88, 26.85, 26.12, 22.39, 7.82.
MS (EI, 70 eV) m/z 166 (M+, 10.85%), 95 (M+ - CO-CH3-
CCH3-H, 16.48%), 82 (COCC(CH3)2, 34.96%), 67 (COCCCH3,
42.92%); MS (CI, 70 ev) m/z 167 (MH+, 100%), 151 (MH+
-
CH3, 87.00%); HRMS (CI) calcd (C11H18O, MH+) 167.1435, obsd
167.1430.
11a : 1H NMR (CDCl3) δ 4.10-3.72 (m, 4H), 2.80 (sept, J 2′,3′
) J 2′,3′′ ) 7 Hz, 1H), 2.50-1.30 (m, 11H), 1.1 (s, 3H), 0.93 (d,
J 2′,3′ ) 7 Hz, 3H), 0.82 (d, J 2′,3′′ ) 7 Hz, 3H).
P r ep a r a t ion of ∆1,7-8-Isop r op ylb icyb lo[5.1.0]oct a n e
(14a ) a n d ∆1,7-8-Eth ylbicyblo[5.1.0]octa n e (14b). The title
compounds were prepared from alkylidenecycloheptanones 12a
and 12b, respectively, as previously described by Friedrich and
co-workers9 (see Scheme 1), with the following minor modifica-
tions. After the preparation of tosylhydrazones 13 in methanol,
the solvent was rotary evaporated at room temperature and
the colored residue recrystallized from CH2Cl2/pentane. The
white crystals were washed with methanol chilled to -70 °C.
Cyclopropanes 14a and 14b (retention times: ca. 16 min) were
separated by GC34b at 90 °C (injector and detector at 100 °C)
with a flow rate of 200 mL/min. Compounds 13 and 14 are
known;9 the substantially improved and missing spectral data
are recorded below.
11b: 1H NMR (CDCl3) δ 4.13-3.81 (m, 4H), 2.99 (dd, J 6,7a
) 10 Hz, J 6,7b ) 4 Hz, 1H), 2.45 (ABq of q, J gem ) 18 Hz, J vic
2
′,3′ ) 7 Hz, 2H), 1.89-1.26 (m, 10H), 1.16 (s, 3H), 0.89 (t, J 2′.3′
) 7 Hz, 3H); 13C NMR (CDCl3) δ 112.66, 74.20, 63.70, 58.20,
44.86, 31.58, 28.86, 28.55, 25.94, 25.08, 24.01, 7.90.
Z-12a : Rf (5% ethyl acetate in hexane) 0.20; 1H NMR
(CDCl3) δ 2.89 (sept, J 3′,4′ ) 7 Hz, 1H), 2.51-2.38 (m, 2H),
2.27-2.19 (m, 2H), 1.75-1.63 (m, H4, 6H), 1.62 (s, 3H), 0.96
(d, J 3′,4′ ) 7 Hz, 6H); 13C NMR (CDCl3) δ 210.84, 143.20, 136.63,
43.72, 31.42, 30.28, 28.79, 28.15, 24.35, 20.95, 11.63; HRMS
calcd (C12H20O, M+) 180.1514, obsd 180.1509.
E-12a : Rf (5% ethyl acetate in hexane) 0.27; 1H NMR
(CDCl3) δ 2.85 (sept, J 3′,4′ ) 7 Hz, 1H), 2.55-2.41 (m, 2H),
2.37-2.19 (m, 2H), 1.73-1.60 (m, 6H), 1.59 (s, 3H), 1.01 (d,
J 3′,4′ ) 7 Hz, 6H); 13C NMR (CDCl3) δ 210.94, 144.01, 135.82,
43.74, 30.46, 29.81, 29.16, 27.99, 24.33, 20.41, 13.37; HRMS
calcd (C12H20O, M+) 180.1514, obsd 180.1511.
Z-12b: Rf (10% ethyl acetate in hexane) 0.27; 1H NMR
(CDCl3) δ 2.57-2.44 (m, 2H), 2.38-2.28 (m, 2H), 2.12 (2q, J 3′,4′
) 7 Hz, 2H), 1.85 (s, 3H), 1.77-1.58 (m, 6H), 1.05 (t, J 3′,4′ ) 7
Hz, 3H); 13C NMR (CDCl3) δ 209.50, 142.36, 136.87, 43.81,
30.67, 28.97, 28.68, 28.51, 24.45, 18.03, 13.31; HRMS calcd
(C11H18O, M+) 166.1358, obsd 166.1355.
13a , Ma jor isom er : 1H NMR (CDCl3) δ 7.92-7.81 (m, 2H),
7.43-7.26 (m, 2H), 5.55 (s, 1H), 2.89 (sept, J 3′,4′ ) J 3′,4′′ ) 7
Hz, 1H), 2.45 (s, 3H), 2.25-1.35 (m, 10H), 1.53 (s, 3H), 0.96
(d, J 3′,4′ ) J 3′,4′′ ) 7 Hz, 6H); Min or isom er : 1H NMR (CDCl3)
δ 7.92-7.81 (m, 2H), 7.43-7.26 (m, 2H), 5.55 (s, 1H), 2.89
(sept, J 3′,4′ ) J 3′,4′′ ) 7 Hz, 1H), 2.45 (s, 3H), 2.25-1.35 (m,
10H), 1.13 (s, 3H), 0.69 (6H, d, J 3′,4′ ) J 3′,4′′ ) 7 Hz); Z-E
m ixtu r e: 13C NMR (CDCl3) δ 162.39, 143.73, 137.80, 137.48,
135.85, 128.09, 126.72, 36.22-25.83, 21.55, 18.43, 12.39.
13b, Ma jor isom er : 1H NMR (CDCl3) δ 7.88-7.82 (m, 2H),
7.30-7.27 (m, 3H), 2.46 (s, 3H), 2.25-1.40 (m, 10H), 2.03 (q,
J 3′,4′ ) 7 Hz, 1H), 1.63 (q, J 3′,4′ ) 7 Hz, 1H), 1.62 (s, 3H), 0.97